There is growing interest in the role of microorganisms in human health and disease, with
evidence showing that new types of biotherapy using engineered bacterial therapeutics …

Human papillomavirus (HPV) is widely known as a cause of cervical intraepithelial
neoplasia (CIN) and cervical cancer. The mechanisms involved have been studied by …

Nanoparticles and bacteria can be used, independently, to deliver genes and proteins into
mammalian cells for monitoring or altering gene expression and protein production. Here …

Abstract Development of HPV-associated cancers not only depends on efficient negative
regulation of cell cycle control that supports the accumulation of genetic damage, but also …

Invasive carcinoma of the cervix (ICC) is the second most common cancer in women
worldwide. Lm-LLO-E7 vaccine is a live-attenuated Listeria monocytogenes (Lm) that …

We contrast the efforts to treat ovarian cancer and cervical cancer through vaccination
because of their different pathobiology. A plethora of approaches have been developed for …

Listeria monocytogenes, a Gram-positive facultative anaerobic bacterium, is becoming a
popular vector for cancer immunotherapy. Indeed, multiple vaccines have been developed …

Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …

For over a century, inactivated or attenuated bacteria have been employed in the clinic as
immunotherapies to treat cancer, starting with the Coley's vaccines in the 19th century and …

Once feared as a deadly intracellular bacterium with the extraordinary capacity to survive a
wide array of arduous external stressors, Listeria monocytogenes is increasingly recognized …